Clinical Trial Update: INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating tiotropium and olodaterol for COPD outcomes, genomics, and neutrophilic inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• olodaterol (olodaterol)
• tiotropium (tiotropium)

Snippet

Sponsor: University of Dundee | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED